Claims hygiene for SME brands: when marketing language becomes a compliance risk

GlobalRisk: HighAction: Labeling August 6, 2026

Owner brief

Business impact

If your ads promise “medical-grade” results or “toxin-free” certainty, pause the campaign until RA reviews substantiation and jurisdiction rules.

Regulatory brief

For RA / compliance

Map claim types to substantiation files. Separate cosmetic vs drug-like framing for US; align with CPR/claims guidance for EU. Sample content only.

Full regulatory brief for members

Join to unlock RA-level detail, references, and archive access.

View membership
Scroll to Top